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ABSTRACT
Objective: When tobacco smokers quit, between half
and two-thirds quit unassisted: that is, they do not
consult their general practitioner (GP), use
pharmacotherapy (nicotine-replacement therapy,
bupropion or varenicline), or phone a quitline. We
sought to understand why smokers quit unassisted.
Design: Qualitative grounded theory study (in-depth
interviews, theoretical sampling, concurrent data
collection and data analysis).
Participants: 21 Australian adult ex-smokers (aged
28–68 years; 9 males and 12 females) who quit
unassisted within the past 6 months to 2 years.
12 participants had previous experience of using
assistance to quit; 9 had never previously used
assistance.
Setting: Community, Australia.
Results: Along with previously identified barriers to
use of cessation assistance (cost, access, lack of
awareness or knowledge of assistance, including
misperceptions about effectiveness or safety), our
study produced new explanations of why smokers quit
unassisted: (1) they prioritise lay knowledge gained
directly from personal experiences and indirectly from
others over professional or theoretical knowledge;
(2) their evaluation of the costs and benefits of quitting
unassisted versus those of using assistance favours
quitting unassisted; (3) they believe quitting is their
personal responsibility; and (4) they perceive quitting
unassisted to be the ‘right’ or ‘better’ choice in terms
of how this relates to their own self-identity or self-
image. Deep-rooted personal and societal values such
as independence, strength, autonomy and self-control
appear to be influencing smokers’ beliefs and
decisions about quitting.
Conclusions: The reasons for smokers’ rejection
of the conventional medical model for smoking
cessation are complex and go beyond modifiable or
correctable problems relating to misperceptions or
treatment barriers. These findings suggest that GPs
could recognise and respect smokers’ reasons for
rejecting assistance, validate and approve their
choices, and modify brief interventions to support
their preference for quitting unassisted, where
preferred. Further research and translation may
assist in developing such strategies for use
in practice.
INTRODUCTION
Smoking cessation researchers, advocates
and healthcare practitioners have tended to
emphasise that the odds of quitting success-
fully can be increased by using pharma-
cotherapies such as nicotine-replacement
therapy (NRT), bupropion and varenicline1
or behavioural support such as advice from a
healthcare professional2–5 or from a tele-
phone quitline.6 However, instead of using
one or more of these forms of assistance, it
appears most quit attempts are unassisted7
and most long-term and recent ex-smokers
quit without pharmacological or professional
assistance.8
Researchers have identified a number of
issues relating to the choice to use assistance.
They generally conclude that failure to use
assistance can be explained by treatment-
related issues such as cost and access, and
patient-related issues such as lack of aware-
ness or knowledge about assistance, includ-
ing misperceptions about the effectiveness
and safety of pharmacotherapy or concerns
about addiction.9–12
Strengths and limitations of this study
▪ The qualitative design allowed us to extend the
existing literature on barriers and facilitators of
assistance utilisation to provide a more in-depth
discussion of the complex reasons of why
smokers may choose to quit unassisted.
▪ Concurrent data collection and analysis allowed
interesting, unanticipated findings to be followed
up and explored in subsequent interviews.
▪ Asking ex-smokers to talk about previous
assisted and unassisted quit attempts provided
new insights into why some smokers go on to
quit unassisted.
▪ As participants were ex-smokers who had quit
unassisted between 6 months and 2 years ago, it
is possible that their recollections may have been
subject to recall bias.
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The policy and practice response to the low uptake of
cessation assistance has typically focused on improving
awareness of, access to, use of assistance and in particu-
lar, pharmacotherapy. NRT, bupropion and varenicline
are often provided free-of-charge or heavily subsidised
by the government or health insurance companies.13–15
NRT is on general sale in pharmacies and supermarkets,
and is widely promoted through direct-to-consumer mar-
keting.16 17 Clinical practice guidelines in the UK, USA
and Australia advise clinicians to recommend NRT to all
nicotine-dependent (>10 cigarettes per day) smokers.18–20
Specialist stop-smoking clinics, and dedicated telephone
and online quit services provide smokers with tailored
support and advice.21–23 These products and services
have not had the population-wide impact that might
have been expected from clinical trial results,16 24 25
leading some researchers to suggest that patient-related
barriers such as misperceptions about effectiveness and
safety are a greater impediment than treatment-related
barriers.26 Little attention, however, has been given to
how and why smokers quit unassisted.8 27 If we can
explain how the process of unassisted quitting comes
about and what it is about unassisted quitting that
appeals to smokers, we may be better placed to support
all smokers to quit, whether or not they wish to use
assistance.
We conducted a qualitative study to understand why
half to two-thirds of smokers choose to quit unassisted
rather than use smoking cessation assistance. Smoking
cessation researchers have recently highlighted the
importance of gaining the smokers’ perspective28 29 and
suggested qualitative research might provide the means
of doing so.30 Although a number of qualitative studies
have examined non-use of assistance in at-risk or disad-
vantaged subpopulations,31–33 only a few have looked at
smokers in general.26 34 Cook-Shimanek et al30 report
that few studies have examined explicit self-reported
reasons of why smokers do not use NRT; to our knowl-
edge, none has examined explicit, self-reported reasons
of why smokers do not use prescription smoking cessa-
tion medications.
A qualitative approach was well suited to the research
questions guiding the current study, which were:
(1) What does quitting unassisted mean to smokers?
(2) What factors influence smokers’ decisions to quit
unassisted?
In order to contextualise the findings of our qualitative
study, we also performed a comprehensive review of the
literature on non-use of smoking cessation assistance.
METHODS
Literature review
We searched MEDLINE via OvidSP, PsycINFO via
OvidSP and CINAHL via EBSCO in February 2015 for
articles reporting on non-use of smoking cessation assist-
ance (see online supplementary file 1 for search strat-
egies and results). We complemented this search
strategy by manually searching the reference lists of rele-
vant papers. Articles were included if: (1) the article
reported on non-use of smoking cessation assistance; (2)
the article was published in 2000 or later; and (3) the
article was in English. Articles were excluded if (1) they
reported only on the characteristics or demographics of
smokers who did not use assistance; (2) the study was
evaluating the feasibility of a smoking cessation interven-
tion; or (3) the study reported only on specific subpopu-
lations such as pregnant women, youth or prisoners. We
identified 1066 articles of which 14 met the inclusion
criteria (figure 1). The included papers were not critic-
ally appraised for quality as our intent was not to synthe-
sis the results of the studies, but to report on how the
issue is currently framed.
Qualitative study design
A constructivist grounded theory methodology under-
pinned the study design, research questions, data collec-
tion, analysis and interpretation.35 In a grounded theory
study, data collection and analysis are iterative with each
informing the other. Sampling is theoretically driven,
that is, researchers shape their sampling strategy based
on the developing analysis. Recruitment continues until
theoretical saturation has occurred and an explanation
generated for the process or phenomenon under
investigation.36
Recruitment and participant selection
We recruited from the general community using trad-
itional media (media release, print and online newspaper
articles, talk-back radio) as well as social media (Twitter,
Facebook). Potential participants were screened for eligi-
bility. Eligible participants were adult (18+ years of age)
ex-smokers who had quit unassisted in the previous
6 months to 2 years. Risk of relapse to smoking, which
reduces with time quit,37 38 was balanced against poten-
tial for recall bias.39 Participants’ smoking and quitting
histories (eg, cigarettes per day, years smoking, number
and type of prior quit attempts) and basic demographic
information (eg, age, gender, education, income and
geographical location) were collected. Eligible partici-
pants were initially purposively sampled (n=9), and then
theoretically sampled on the basis of their screening
information (n=12). We selected ex-smokers with varied
smoking and quitting histories from a diverse range of
backgrounds. This sampling strategy ensured we gener-
ated rich, relevant and diverse data pertinent to the
research questions and to our evolving theories about
quitting and use/non-use of assistance. Participants were
offered AU$80 reimbursement for sparing their time. We
interviewed 21 ex-smokers who had quit without assist-
ance within the past 6 months to 2 years. Participant
characteristics are summarised in table 1.
Conducting the interviews
Interviews took place between December 2012 and
December 2013. Where geographically feasible,
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participants were encouraged to be interviewed
face-to-face; however, the final decision was left to the
participant. All interviews were conducted by ALS. The
University of Sydney Human Research Ethics Committee
approved all study procedures and materials. Potential
participants were provided with a participant informa-
tion sheet; participants provided written consent for
their participation prior to enrolment in the study.
A semistructured interview guide was used for each
interview, but the specific questions asked reflected the
quitting experiences of the participant and the stage in
data collection. Questions evolved as recruitment and
interviewing progressed, with subsequent interviews
becoming more specific in order to help the develop-
ment of provisional ideas and theories. Both the screen-
ing questionnaire and interview guide were pilot tested
prior to start of the study.
Data capture, coding and analysis
Interviews were audio recorded and transcribed verba-
tim; interviews lasted between 37 min and 1 h 50 min.
Field notes were made directly after each interview.
Theoretical saturation was reached after 21 interviews; at
this point our evolving ideas and theories were fully evi-
denced from the data, and few or no new insights were
forthcoming from participants.
Data management and analysis were aided by use of
computer-assisted qualitative data analysis software NVivo
10 (QSR International). Data analysis involved (1) using
the first 5 interview transcripts and field notes to create
detailed codes reflecting what appeared to be most
important to those participants; (2) sorting the codes
into a coding hierarchy; (3) coding the subsequent tran-
scripts, and revising the codes and coding hierarchy as
necessary; (4) comparing and contrasting data from
within and between interviews; and (5) writing memos.
During memoing, the researcher documented the ana-
lytical thinking driving the coding process and explored
relationships between categories.
Coding and memoing were performed by ALS. The
codes, coding hierarchy, memos and evolving ideas and
theories were regularly discussed with the other
researchers. In addition to experience in tobacco
control, each of the researchers had expertise in differ-
ent areas relevant to the project, including smoking ces-
sation, behavioural psychology, bioethics and qualitative
health research methodology. The diversity of viewpoints
and experiences were critical to the interpretation of
the data.
When the researchers had established the central cat-
egories in the analysis, these were mapped against what
had been reported in the existing literature. Those
Figure 1 Identification and screening of eligible articles for inclusion in the literature review. *Articles were excluded if they
reported only on (1) the characteristics of smokers who did not use assistance; (2) the feasibility/acceptability of a smoking
cessation intervention; (3) specific subpopulations, for example, culturally and linguistically diverse populations, pregnant women,
or at-risk populations such as hospital patients or youth.
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categories that had not previously been discussed in the
literature were analysed further and connections
between them explored.
RESULTS
Study perspective
Key categories identified in our data were mapped
against reasons for non-use of assistance as reported in
the smoking cessation literature (table 2). These
included treatment-related and patient-related issues, as
well as a number of social–environmental issues. We
were encouraged by the consistency between our cat-
egories and the findings of previous research.
Our central analytical focus, however, was the original,
previously unreported categories in our analysis (table 3).
When grouped, these suggested 4 new processes that
could help explain unassisted quitting:
1. Prioritising lay knowledge;
2. Evaluating assistance against unassisted quitting;
3. Believing quitting is their personal responsibility;
4. Perceiving quitting unassisted to be the ‘right’ or
‘better’ choice.
Illustrative quotes for each category are provided in
table 3.
Prioritising lay knowledge
Many participants expressed views about assistance that
were at odds with accepted knowledge in smoking cessa-
tion on the effectiveness, side effects and long-term
safety of assistance (table 2). These ‘misperceptions’
about assistance appear to arise because participants’
personal experiences and lay knowledge of assistance do
not tally with what they have been told about assistance
by their general practitioner (GP), pharmacist or
through direct-to-consumer marketing of NRT by
pharmaceutical companies. The gulf between what
smokers have personally experienced or heard from
others, and what health professionals are telling them
was particularly evident in participants’ talk of unmet
expectations of what assistance could realistically do for
them. For many, the experience of using assistance had
not been as expected, including not being as effective as
they had believed it would be.
Participants talked of the importance of shared narra-
tives of assistance that were predominantly negative and
shared narratives of quitting unassisted that were pre-
dominantly positive. Shared stories of assistance—both
personal and secondhand—were stories of failure to
quit, and of unpleasant and sometimes serious side
effects. In contrast, talk about quitting unassisted often
featured family and friends who had managed to quit
successfully on their own.
In order to resolve the tension between what is going
on in ‘their world’ and what the professional medical
and healthcare worlds are endorsing, participants priori-
tised what they knew: either directly from their own
experiences or indirectly from ‘trusted’ sources. As a
consequence, participants appeared to discount profes-
sional advice in favour of their own first-hand quitting
experiences and the collective narratives of quitting suc-
cesses and failures that circulated in their social groups.
This lay knowledge-making based on personal and col-
lective experiences appears to be a powerful force at
play in smokers’ decisions about quitting.
Evaluating assistance against unassisted quitting
On the whole, participants did not seem to be quitting
unassisted because of a lack of awareness or knowledge
about the assistance available to them. Instead partici-
pants appeared to have engaged in an evaluation of the
perceived costs and benefits of using assistance com-
pared with the costs and benefits of quitting unassisted.
Factors in this cost–benefit balance related primarily to
Table 1 Participant characteristics
Characteristic
Participants
(n=21)
Gender
Male 9
Female 12
Age (years)
20–29 1
30–39 5
40–49 3
50–59 8
60–69 4
Geographical location*
Major cities 13
Inner regional Australia 2
Outer regional Australia 6
Remote Australia 0
Very remote Australia 0
Total household income (before tax) (AU$)†
≤30K 4
>30–60K 3
>60–90K 3
>90–120K 6
>120K 4
Experience of assistance
Had never tried to quit before 2
Had never used assistance to quit 7
Had previously used assistance to quit 12
Previous quit attempts
None 2
<3 10
3–10 7
>10 2
Recruitment method‡
Traditional 12
Social media 9
Interview format
Face-to-face 8
Telephone 13
*Classified according to the Australian Standard Geographical
Classification Remoteness Area system.
†One participant did not answer the question on income.
‡Traditional: media release, print and online newspaper articles,
talk-back radio; social media: Twitter, Facebook.
4 Smith AL, et al. BMJ Open 2015;5:e007301. doi:10.1136/bmjopen-2014-007301
Open Access
group.bmj.com on April 2, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
T
a
b
le
2
D
a
ta
fr
o
m
c
u
rr
e
n
t
s
tu
d
y
m
a
p
p
e
d
a
g
a
in
s
t
k
n
o
w
n
is
s
u
e
s
re
la
te
d
to
n
o
n
-u
s
e
o
f
s
m
o
k
in
g
c
e
s
s
a
ti
o
n
a
s
s
is
ta
n
c
e
S
tu
d
ie
s
Is
s
u
e
s
re
la
te
d
to
n
o
n
-u
s
e
o
f
s
m
o
k
in
g
c
e
s
s
a
ti
o
n
a
s
s
is
ta
n
c
e
T
re
a
tm
e
n
t-
re
la
te
d
is
s
u
e
s
P
a
ti
e
n
t-
re
la
te
d
is
s
u
e
s
S
o
c
ia
l-
e
n
v
ir
o
n
m
e
n
ta
l
is
s
u
e
s
C
o
s
t
A
c
c
e
s
s
(e
g
,
d
e
la
y
in
g
e
tt
in
g
p
re
s
c
ri
p
ti
o
n
;
G
P
a
s
g
a
te
k
e
e
p
e
r)
L
a
c
k
o
f
a
w
a
re
n
e
s
s
o
r
k
n
o
w
le
d
g
e
a
b
o
u
t
a
s
s
is
ta
n
c
e
(i
n
c
lu
d
in
g
m
is
p
e
rc
e
p
ti
o
n
s
):
O
v
e
rc
o
n
fi
d
e
n
c
e
in
o
w
n
a
b
il
it
ie
s
N
o
t
re
g
a
rd
e
d
a
s
a
p
p
ro
p
ri
a
te
:
S
o
c
ia
l
n
o
rm
s
(e
g
,
re
la
ti
n
g
to
u
s
e
o
f
a
s
s
is
ta
n
c
e
o
r
p
e
rc
e
p
ti
o
n
o
f
a
s
s
is
ta
n
c
e
u
s
e
rs
)
E
ff
e
c
ti
v
e
n
e
s
s
/
h
o
w
a
s
s
is
ta
n
c
e
w
o
rk
s
S
a
fe
ty
/s
id
e
e
ff
e
c
ts
/
fu
tu
re
h
e
a
lt
h
/n
e
w
a
d
d
ic
ti
o
n
A
v
a
il
a
b
il
it
y
(e
g
,
h
o
w
to
g
e
t
N
R
T
,
fr
e
e
o
r
s
u
b
s
id
is
e
d
p
h
a
rm
a
c
o
th
e
ra
p
y
o
r
b
e
h
a
v
io
u
ra
l
s
u
p
p
o
rt
)
F
o
r
th
e
s
m
o
k
e
r
(e
g
,
n
o
t
a
d
d
ic
te
d
e
n
o
u
g
h
;
d
o
n
o
t
li
k
e
u
s
in
g
m
e
d
ic
a
ti
o
n
s
)
F
o
r
q
u
it
ti
n
g
(e
g
,
d
e
a
ls
w
it
h
a
d
d
ic
ti
o
n
n
o
t
b
e
h
a
v
io
u
ra
l/
p
s
y
c
h
o
lo
g
ic
a
l
a
s
p
e
c
ts
)
Q
u
a
n
ti
ta
ti
v
e
E
tt
e
r
a
n
d
P
e
rn
e
g
e
r
9
✓
✓
B
a
n
s
a
l
e
t
a
l1
0
✓
✓
✓
C
u
m
m
in
g
s
e
t
a
l4
0
✓
✓
H
a
m
m
o
n
d
e
t
a
l4
1
✓
✓
M
o
o
n
e
y
e
t
a
l4
2
✓
✓
G
ro
s
s
e
t
a
l1
1
✓
✓
S
h
if
fm
a
n
e
t
a
l1
2
✓
✓
V
o
g
t
e
t
a
l2
6
*
✓
V
o
g
t
e
t
a
l4
3
†
✓
✓
B
o
rl
a
n
d
e
t
a
l4
4
✓
W
ill
e
m
s
e
t
a
l4
5
✓
✓
✓
✓
✓
C
o
b
b
e
t
a
l4
6
✓
C
o
o
k
-S
h
im
a
n
e
k
e
t
a
l3
0
✓
✓
✓
✓
✓
✓
✓
Q
u
a
lit
a
ti
v
e
V
o
g
t
e
t
a
l2
6
*
✓
✓
✓
✓
✓
✓
✓
V
o
g
t
e
t
a
l4
3
†
✓
✓
U
p
p
a
l
e
t
a
l3
4
✓
✓
✓
✓
D
a
ta
fr
o
m
c
u
rr
e
n
t
s
tu
d
y
✓
✓
✓
✓
✓
✓
✓
✓
*V
o
g
t
e
t
a
l2
6
re
p
o
rt
e
d
d
a
ta
fr
o
m
tw
o
s
tu
d
ie
s
,
o
n
e
q
u
a
lit
a
ti
v
e
a
n
d
o
n
e
q
u
a
n
ti
ta
ti
v
e
†
V
o
g
t
e
t
a
l4
3
re
p
o
rt
e
d
d
a
ta
fr
o
m
tw
o
s
tu
d
ie
s
,
o
n
e
q
u
a
lit
a
ti
v
e
a
n
d
o
n
e
q
u
a
n
ti
ta
ti
v
e
.
G
P
,
g
e
n
e
ra
l
p
ra
c
ti
ti
o
n
e
r;
N
R
T
,
n
ic
o
ti
n
e
re
p
la
c
e
m
e
n
t
th
e
ra
p
y
.
Smith AL, et al. BMJ Open 2015;5:e007301. doi:10.1136/bmjopen-2014-007301 5
Open Access
group.bmj.com on April 2, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
the perceived convenience of unassisted quitting (in
terms of time to being ‘quit’ and the effort required to
make the quit attempt happen) and the importance of
short-term financial savings. These arguments were
sometimes explicit and sometimes implicit.
Participants talked about wanting to quit now, immedi-
ately. NRT and smoking cessation medication both
involve a treatment period in which the smoker is still a
smoker: they cannot yet call themselves a ‘non-smoker’.
In their opinion, use of assistance essentially delays their
Table 3 The four analytical categories that explain the process and meaning of quitting unassisted, with illustrative quotes
Category Participant quotes
Prioritising lay knowledge
▸ Valuing personal experiences
▸ Being influenced by shared/collective knowledge
‘I’ve done this, I’ve done the gum before, it’s my turn to just do it by myself
with common sense and willpower.’ Female, 57 years old
‘I’ve known a couple of people around town that have tried to give up with
patches and that and they’ve gone 3 or 4 weeks and they’ve started
smoking again and all that.’ Female, 52 years old
‘I’ve got friends that have used the patches and the gum a lot. They’ve been
unsuccessful. They’ve done the gum and the patches, I don’t know how
many times. They’ve spent so much money on them, and they just cannot
make it work.’ Female, 31 years old
‘Well [assistance] hadn’t worked in the past and I didn’t think—I’d come to
the realisation that it was just in the mind, it was just a matter of willpower, it
was just a matter of saying no and sticking to it.’ Male, 59 years old
Evaluating assistance against unassisted quitting
▸ Weighing up the ‘value’ assistance brings to them and their
quit attempt (is it worth using assistance to quit?)
▸ Wanting to save money now (spending money to quit is
irrational, especially on something that brings no ‘pleasure’)
▸ Wanting to quit ‘instantly’, be a non-smoker now (which
assistance does not allow)
▸ Disliking the ‘inconvenience’ of assistance (assistance is too
complicated, too fiddly)
▸ Associating assistance with additional effort (eg, adopting
new, but temporary, routines)
‘It was a big thing that if I’m going to save money by not smoking then why
should I spend money on not smoking.’ Male, 45 years old
‘The cigarettes, that’s the fun. Why would you spend $20 on non-fun? ’
Female, 34 years old
‘I found [NRT] expensive. I thought that if you’re going to get nicotine
anyway at least there should be some positive reason for it.’ Female,
56 years old
‘If I’m going to quit smoking I’m going to do it cold turkey and get it over and
done with.’ Female, 52 years old
‘I went to the GP and he said oh, you need to continue to smoke though for
a couple of—what was it? It is a week? I was like oh no, but I want to stop
now.’ Female, 34 years old
‘It’s too much of a hassle… You’ve got to go out and buy the thing. You’ve
got to stick it on or chew it or unwrap it.’ Male, 61 years old
Believing quitting is their personal responsibility
▸ Smoking and quitting are personal problems (and the
responsibility of the individual)
▸ Smoking and quitting are not medical conditions
▸ The smoker is best placed to know how to quit, what
will work
‘It’s my problem. Not problem, I think that’s a bad choice of words, but I was
the one smoking.’ Male, 28 years old
‘That’s so important that you don’t make an issue out of it. It is a personal—
you’re right. You are so right. It is a personal thing.’ Male, 61 years old
‘Yeah, okay, I screwed up, I smoked for years, I really need to do something
about this and cope with it.’ Female, 57 years old
‘I’m not much of someone to go to a doctor unless there was, unless
I thought there was a serious problem with myself I don’t normally go to a
doctor.’ Male, 45 years old
‘I’m independent and I’m stubborn and that’s the only way that I knew how
to do it. I wasn’t going to—I’m not a person to ask for help. So I don’t think
I would have asked for help to quit smoking.‘ Female, 31 years old
‘OK I did the Champix, I stopped for maybe—I can’t remember if it was 2 or
3 months—but like it didn’t work because it actually, the change sort of
wasn’t from within,’ Female, 56 years old
‘I think quitting cold turkey, you’re going to have more chance of actually
[staying] a non-smoker, if you quit cold turkey....because I think that you
need that willpower to stay motivated to not smoke.’ Female, 31 years old
‘Because grand scheme of things, it’s always your willpower that’s going to
stop you. So you might be able to use other methods to help you quit
smoking, but six months down the track, you need to have that willpower to
stop you doing that again.’ Female, 31 years old
‘I feel a sense of accomplishment in knowing that I did it cold turkey.
Knowing that I didn’t have to go to other means to do it. That I was able to
use my willpower.’ Female, 31 years old
Perceiving quitting unassisted to be the ‘right’ or ‘better’ choice
▸ Quitting unassisted is the ‘best’ way to quit
▸ Equating quitting unassisted with being serious
about quitting
‘I think I just didn’t want to [use assistance], I just felt that for me to do it
properly I actually had to be able to do it myself.’ Female, 50 years old
‘[Taking medication] had crossed my mind, but I’m a fairly stubborn person
I suppose. I don’t really—I believe that I should be able to do it myself,
without those sorts of things.’ Male, 31 years old
‘I think that if you’re truly committed you don’t need anything ’ Female,
56 years old
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progression to being totally quit. In contrast, going ‘cold
turkey’ (ie, quitting suddenly without cutting down or
using any assistance) provides an immediate satisfaction
and instant non-smoker status. There often appeared to
be a sense of urgency or a need for an immediate and
complete change of status in those who opted to quit
unassisted.
Using assistance was also associated with an investment
of practical and logistical effort. Assistance required the
adoption of new—but temporary—routines and habits.
It was a middle ground or half-way house through which
the smoker would have to pass. They would have to com-
plete this ‘assistance’ phase before being able to adopt
yet another set of routines and habits to become
nicotine-free or drug-free. These temporary routines
associated with assistance included obtaining or purchas-
ing assistance, carrying it around and remembering to
use it. For some this temporary, additional set of rou-
tines appeared simply too complex, too bothersome and
too high a price to pay in terms of the inconvenience
generated.
For a number of participants, spending money to quit,
especially when quitting was motivated by a desire to
save money, appeared counter-intuitive. For such partici-
pants, thoughts were focused on the here and now, on
the short-term rather than long-term savings. Few partici-
pants appeared to regard money spent on assistance as a
long-term investment in future financial savings. As a
consequence, using assistance to quit was viewed as a
barrier to maximising potential savings while quitting.
For NRT specifically, this balancing of the pros and cons
extended beyond the financial cost of cigarettes versus
cost of NRT to the perceived pleasure that the financial
spend was likely to provide. Spending $20 on cigarettes
was reasonable because it would deliver pleasure; spend-
ing $20 on something that was going to make you miser-
able was not. An unwillingness to spend on NRT also
appeared related to an inability to reconcile nicotine’s
dual role as part of the problem and the solution, and
to fears of becoming addicted to NRT gums, patches or
inhalers.
Believing quitting is their personal responsibility
Quitting appeared to be an intensely individual experi-
ence and one that the smoker believed only they could
take charge of. Ultimately quitting was something they
had to face themselves. Many participants seemed to
have reached a point where they regarded smoking to
be their problem and quitting to be their personal
responsibility. Quitting was, therefore, not necessarily
something that could be helped or facilitated by exter-
nal support (be it from family, friends or health
professionals).
Participants often talked about being the person best
placed to know why they smoked, why they wanted to
quit, and what was likely to work for them. To these par-
ticipants, external help or assistance was unlikely to be
useful or necessary. For many this appeared to be
because they had previous experience of unsuccessful
assisted quit attempts (with, eg, over-the-counter NRT,
prescription NRT, smoking cessation medications or
behavioural support) and had learnt that for them,
assistance was unhelpful or solved only part of the
problem. Conversely, other participants had not previ-
ously used professional or pharmacological support to
quit and therefore, did not see the need to do so now.
Others simply did not equate smoking with being ill, or
regard smoking and quitting as medical conditions: this
meant medical support was not appropriate and little
benefit would be gained from involving a GP in the quit
attempt. Several participants implied that a GP would be
able to offer only generic or lay quitting advice that was
unlikely to be relevant to them personally: in other
words, from the participant’s perspective, the GP could
add little to the participant’s own personal store of quit-
ting experiences.
A number of participants also appeared to have an
issue with adopting a substitute behaviour (ie, NRT or
smoking cessation medication). To these participants,
the use of NRT or drugs meant that they were still
dependent on nicotine or another substance to deal
with their need for nicotine. If they really wanted to quit
and to quit for good, they needed to take that step
themselves, which to them essentially precluded use of
assistance and in particular, NRT.
Perceiving quitting unassisted to be the ‘right’ or
‘better’ choice
In contrast to the dominant medical and health promo-
tion discourse about quitting unassisted being undesir-
able or even foolhardy, for many participants quitting
unassisted was the ‘right’ or ‘better’ way to quit. This
belief appeared to be closely associated with what partici-
pants referred to as ‘being serious’ about quitting. It
appears that underlying these beliefs may be a set of
values that the participant and perhaps also Australian
society, as a whole, endorses.
Participants talked, either explicitly or implicitly, about
the values that were important to them in relation to
their quit attempt: independence, strength, autonomy,
self-control and self-reliance. These values are, broadly
speaking, also reflective of values central in many
western societies and cultures. It seems likely that these
broadly held values were influential in shaping partici-
pants’ beliefs about quitting unassisted being the right
or better choice and the belief that quitting was ‘up to
me’. Quitting unassisted allowed the participant to
realise a need to feel independent, in control and
autonomous, something that they would not necessarily
have felt if they had used assistance. Some participants
even suggested that seeking help from a GP or another
source such as the Quitline would be tantamount to
admitting failure. The independent nature of their quit
attempt was seen as an important contributor to the
success of that attempt.
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In summary, many participants believed they had
achieved something of value by quitting unassisted, and
appeared to take this achievement as an indicator of the
strength of their moral character. In this context, quit-
ting unassisted was presented as a morally superior
option; quitting unassisted was evidence of personal
virtue. It is important to note, however, that this was
rarely used as a measure of the moral worth of others.
Participants rarely suggested that other smokers who
used assistance to quit were morally inferior. Rather,
they presented their final, unassisted quit attempt as evi-
dence that their personal virtue had increased over
time, thus bolstering their own sense of identity and
self-worth.
DISCUSSION
Principal findings
In this community sample of ex-smokers who had quit on
their own without consulting their GP or using smoking
cessation assistance, issues of cost and access to assistance,
misperceptions relating to the effectiveness and safety of
pharmacotherapy, and confidence in their ability to quit
on their own affected their decision to quit unassisted.
This was consistent with earlier quantitative and qualita-
tive research (table 2). However, we found that the influ-
ences on non-use of assistance were more complex,
involving careful judgements about the value of knowl-
edge, the value of different quitting strategies, the
importance of taking personal responsibility and the
moral significance of quitting alone. Future efforts to
improve uptake of assistance may need to take some of
these influences into consideration.
In an effort to understand what appears to be conflict-
ing advice about quitting and how to quit successfully,
participants appear to fall back on trusting their intu-
ition or common sense, giving preference to their per-
sonal and shared knowledge of quitting over
professional or theoretical knowledge. Lay knowledge
(or lay epidemiology) has previously been used to
understand how health inequalities develop in
smokers,47–49 to inform health-promotion practices in
smoking cessation,50 and to explain the range of self-
exempting beliefs used by smokers to avoid quitting.51
Our study is the first to demonstrate how lay knowledge
influences non-use of assistance when attempting to quit
smoking.
Participants who quit on their own often appeared
reluctant to consult their GP, primarily because they did
not view smoking or quitting as an illness, reflecting
what others have also reported.52 53 Our analyses show
that this reluctance to consult a GP may also be because
smokers perceive the GP has little to offer beyond the
smoker’s own lay knowledge, reflecting what others have
recently reported for smoking cessation consultations in
general practice in the UK.54 This reluctance to consult
a GP may be reinforced if the smoker is hesitant about
using pharmacotherapy or if they believe smoking is not
a ‘doctorable’ condition. Doctorable is a term coined by
Heritage and Robinson55 to explain the way in which
patients in the USA account for their visits to primary
care physicians and to demonstrate how patients orien-
tate to a need to present their concerns as doctorable.
Before visiting a physician, patients make a judgement
as to whether they require medical help. They are aware
that the physician will subsequently judge their judge-
ment when they present at the surgery. It is conceivable
that this need to present only when the individual per-
ceives the condition to be doctorable could apply not
just to smoking cessation, but to other difficult-to-change
health behaviours such as losing weight or getting fit.
In addition to judgements relating to the value of lay
knowledge, our study highlights how smokers make jud-
gements about the value of different quitting strategies
based on perceptions of time and effort required, con-
venience and cost. This process of evaluation has been
reported for decisions related to the taking of other pre-
scribed medications.56 Pound et al 56 reported that
patients often weigh-up the benefits of taking a medi-
cine against the costs of doing so and are often driven
by an overarching desire to minimise medicine intake.
In the current study, this evaluation of different quitting
strategies often resulted in the participant forming a
negative opinion of assistance and in particular, of NRT.
Given nicotine’s complicated history and transformation
from an addictive, toxic and potentially harmful drug to
a medically useful drug it was not surprising that many
participants found it difficult to reconcile nicotine’s por-
trayal as being part of the problem and a possible solu-
tion,57 and as a result appeared to be resisting use of
medications to assist them to quit.
Layered underneath the prioritising of lay knowledge
and the evaluation of different quitting strategies were
deep-rooted cultural values, such as independence,
strength, self-reliance, self-control and autonomy, which
influenced participants’ views on assisted and unassisted
quitting. Lay knowledge in combination with these
multilayered influences lead many participants to
believe that quitting unassisted was the ‘right’ or ‘better’
way to quit, that the participant was personally respon-
sible for their quitting and that quitting unassisted was a
prerequisite for ‘being serious’ about quitting. This key
concept, being serious, is one we believe is critically
important to Australian smokers and one we are explor-
ing further in our ongoing research.
It should be noted that this study included only success-
ful ex-smokers (quit for at least 6 months). Given that
these individuals were interviewed in the context of a suc-
cessful quit attempt, attribution theory58 might provide
some insight into the emergence of independence,
strength, self-control and personal virtue as components
of the successful unassisted quit attempt in these inter-
views. Attribution theory suggests a self-serving bias in
attributions such that success is attributed to internal
factors (such as personal virtue), and failure to external
or situational factors. It might be informative to conduct
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some research with smokers who tried to quit on their
own and failed, as well as with ex-smokers who success-
fully quit with assistance to explore whether concepts
relating to external or internal attributions emerge for
these different groups of quitters.
Strengths and limitations
The qualitative design and in particular, the grounded
theory methodology is a strength of this exploratory
study. The concurrent data collection and analysis
allowed unanticipated findings to emerge (such as the
importance of lay knowledge and the sense of the par-
ticipant being personally responsible for their quitting)
and to be followed up and more fully explored in subse-
quent interviews. Allowing ex-smokers to talk about pre-
vious assisted and unassisted quit attempts provided new
insights into why smokers quit unassisted. The qualitative
design of the current study allowed us to extend the
existing literature on barriers and facilitators of assist-
ance utilisation to provide a more in-depth discussion of
the complex reasons for why many smokers may choose
to quit unassisted. By using a sample of ex-smokers from
the general population we were able to broaden previ-
ous research that had focused specifically on at-risk or
disadvantaged subpopulations.31–33 In the current study,
rather than controlling for context, we actively sought to
retain context in order to reveal the historical, social
and cultural factors that may have impacted on quitting
decisions. Limitations of the current study include using
a non-representative sample of ex-smokers. Nonetheless,
we minimised volunteer bias by recruiting directly from
the general community. By recruiting through main-
stream (press releases, newspaper articles and talkback
radio) and social media (Twitter and Facebook), screen-
ing potential participants and providing participants
with financial reimbursement for sparing their time, we
achieved a sample of ex-smokers from diverse socio-
economic backgrounds who varied in age, education,
income, geographical location, prior quitting experi-
ences and prior use of assistance. As participants were
ex-smokers who had quit unassisted between 6 months
and 2 years ago, it is possible that their recollections may
have been subject to recall bias. However, this possibility
was balanced against the potential for relapse to
smoking, which was an important consideration for this
study.
Implications and future research
A proportion of smokers are unlikely to choose to use
assistance to quit smoking or are reluctant to do so. Too
much focus on pharmacological assistance may fail this
group. It may be a more productive and a potentially
more patient-centred approach to acknowledge that for
these smokers quitting unassisted is a valid and poten-
tially effective option.
Evidence-based medicine (EBM) and clinical practice
guidelines prioritise results from randomised controlled
trials (RCTs) and meta-analyses of RCTs. As a
consequence, current smoking cessation guidelines in
the UK,18 USA19 and Australia20 position pharmacother-
apy as first-line therapy for those dependent on nicotine
(>10 cigarettes per day). A range of government policies
ensure pharmacotherapy is free or heavily subsidised,
available on prescription and/or over-the-counter and
that smokers have access to widely promoted and free
quitline advice and support, and/or dedicated
stop-smoking services.
As RCTs are designed to evaluate the efficacy of inter-
ventions, such as medications, in carefully controlled
study populations, they cannot capture and often seek
to eliminate the complexities associated with patients’
lived experiences. This complexity may, however, be of
relevance when making decisions about how to manage
patients with complicated health-related behaviours,
such as smoking. By retaining and examining some of
the complexity surrounding quitting smoking, we have
highlighted how participant’s beliefs, values and prefer-
ences can influence the decision to quit unassisted.
Previous research into patient-centred care has also
identified that respect for a patient’s beliefs and
values,59 needs and preferences,60 and knowledge and
experience61 are central to delivering care that is tai-
lored to the needs of the individual patient. Accordingly,
patient-centred care for smokers may include recognis-
ing and respecting smokers’ reasons for declining assist-
ance, validating and approving their choices and
modifying brief interventions to support their prefer-
ence for unassisted quitting, where preferred.
Healthcare policy does not operate in a vacuum. As
our study indicates, success of any given policy is critic-
ally dependent on the broader social and cultural
context. This is especially true for tobacco control given
the influence of key stakeholders such as the tobacco
industry. Recent research highlights how the tobacco
industry capitalised on the powerful notion of personal
responsibility to frame tobacco problems as a matter for
individuals to solve.62 To our knowledge, our analysis is
the first to indicate smokers do indeed feel personally
responsible for quitting. Smoker’s beliefs about quitting
have been heavily influenced by social and cultural
ideals, some of which are highly likely to have been
shaped by the tobacco industry’s individual choice rhet-
oric. The complexity of how such a rhetoric has influ-
enced smokers has to date been unexplored.
The value placed on lay knowledge and on different
quitting strategies by participants indicates that GPs,
health promotion practitioners and pharmaceutical
companies may be advised to be mindful of the conse-
quences of overselling assistance and potentially unreal-
istically raising smokers’ outcome expectations, further
fuelling the apparent gulf between lay experiences and
expert-derived knowledge. The low absolute efficacy
rates of NRT and stop-smoking medications1 create a
challenge: is it possible to communicate about these pro-
ducts without disheartening smokers or making pro-
mises that may be difficult to deliver?
Smith AL, et al. BMJ Open 2015;5:e007301. doi:10.1136/bmjopen-2014-007301 9
Open Access
group.bmj.com on April 2, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
Cultural values are likely to play a role in the choice to
use assistance or not, and future research should
explore these issues in other cultures. It would be useful
to replicate this study in other cultural contexts and in
countries less advanced in tobacco control to
determine whether the study findings are applicable
across countries, cultural dimensions and stages of the
tobacco epidemic.
For those patients who do seek medical advice, GPs
may need to be cognisant of the role of lay knowledge
and the patient’s evaluation of different quitting strat-
egies when counselling and advising about quitting
smoking. The challenge will be to support those
smokers who wish to quit unassisted while avoiding stig-
matisation of those smokers who want or need assistance
to quit.
CONCLUSION
A smoker’s reluctance to use assistance to quit may
sometimes be difficult to understand. Through this
empirical work we are now able to suggest some explana-
tions for this behaviour.
The reasons for smokers’ rejection of the conventional
medical model for smoking cessation are complex and
go beyond the modifiable or correctable issues relating
to misperceptions or treatment barriers. Lay knowledge
and contextual factors are critically important to a
smoker’s decision to seek or resist assistance to quit.
Smokers prioritise lay knowledge, evaluate assistance
against unassisted quitting, believe quitting is their per-
sonal responsibility and perceive quitting unassisted to
be the right or better option. Accordingly, GPs might
recognise and respect smokers’ reasons for rejecting
assistance, validate and approve their choices, and
modify brief interventions to support their preference
for unassisted quitting, where preferred.
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